Myrcia multiflora
Myrcia multiflora · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Myrcia multiflora is a botanical species that has garnered significant scientific interest due to its potential therapeutic properties. Researchers are increasingly investigating how specific extracts derived from this plant can impact metabolic health. In particular, studies focus on the plant's ability to assist in the management of Diabetes Mellitus. By utilizing concentrated preparations, scientists aim to isolate the bioactive compounds responsible for regulating blood glucose levels. Understanding these mechanisms offers promising new avenues for integrating natural extracts into modern diabetic care strategies.
- Synonyms
- Aulomyrcia Buxifolia · Aulomyrcia Caerulescens · 37 more
- Common names
- Not available
- Family
- Myrtaceae
- Distribution
- Asia-Tropical
- Plant Parts
- Not available
Classification
Common Names
Myrcia multiflora is a versatile plant recognized by a wide variety of regional names. Depending on the local area, it is frequently referred to as Cambuí or cambui. Some communities also identify the species as Pau-mulato, highlighting its diverse linguistic connections. Other traditional names include Arrebenta-boi and pedra hume, reflecting its deep cultural roots. These multiple monikers illustrate the rich botanical heritage associated with this single species.
Sources: Catalogue of Life (COL)
Synonyms
Myrcia multiflora is a complex species that has been identified under several different botanical names throughout history. Many researchers recognize various synonyms for this plant, most notably within the genus Aulomyrcia. Specifically, it has been classified as Aulomyrcia buxifolia, Aulomyrcia caerulescens, and Aulomyrcia caesia. Furthermore, the taxonomic record includes its designations as Aulomyrcia camareana and Aulomyrcia glaucescens. Understanding these overlapping relationships is essential for accurate botanical identification and scientific study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Myrcia multiflora is a distinct member of the kingdom Plantae. Within this vast botanical world, it is classified under the class Equisetopsida. This plant belongs to the specific order Myrtales, which helps define its evolutionary lineage. It is further nested within the Myrtaceae family, a group known for its diverse characteristics. Ultimately, it is identified by its specific genus, Myrcia, which distinguishes it from other related species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Myrtales |
| Family | Myrtaceae |
| Genus | Myrcia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Myrcia multiflora is a plant species primarily characterized by its widespread distribution throughout South America. Within the vast territory of Brazil, it maintains a significant presence across several distinct geographical regions. Its habitat spans from the coastal stretches of the Northeast to the diverse landscapes of the South and Southeast. Additionally, the species is found flourishing in the West-Central areas and throughout much of Northern Brazil. This broad range highlights the plant's remarkable ability to adapt to various Brazilian ecosystems.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Myrcia multiflora is a self-supporting plant that takes the form of a sturdy tree. It reaches a maximum height of approximately 12 meters as it matures. This growth habit allows it to establish a significant presence within its natural habitat.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Myrcia multiflora is part of the Myrcia genus, which is traditionally used in medicine to treat diabetes mellitus. Research into species within this genus reveals that their extracts contain significant phenolic compounds like myricetin and quercetin derivatives. These extracts demonstrate potent inhibitory potential against $\alpha$-glucosidase, outperforming the standard drug acarbose by 90 to 500 times. Furthermore, the plants show a mild inhibitory effect against $\alpha$-amylase, which is crucial for managing blood sugar levels. Consequently, these botanical properties support the traditional use of Myrcia species in managing diabetic conditions.
Preparations
Myrcia multiflora is prepared as extracts to investigate its potential medicinal properties. These extracts are used to identify specific phenolic compounds, such as myricetin and quercetin derivatives. Through this preparation, researchers can evaluate the inhibitory potential of the plant against enzymes like α-glucosidase and α-amylase. The study focuses on how these prepared substances might serve as alternatives for treating diabetes mellitus. Consequently, the extraction process is essential for exploring the therapeutic efficacy of the Myrcia genus.